Vitamin E protects against Alzheimer's amyloid peptide (25-35)-induced changes in neocortical synaptosomal membrane lipid structure and composition

Brain Research

Volumn 786, Issue 1-2, 1998, Pages 270-273

  Koppal, Tanuja ^a   Subramaniam, Ram ^a   Drake, Jennifer ^a   Prasad, M Renuka ^b   Dhillon, Harbhajan ^b   Butterfield, D Allan ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Alzheimer's disease; Amyloid; Electron paramagnetic resonance (EPR); Free radicals; Lipid peroxidation; Vitamin E

Indexed keywords

4 HYDROXYNONENAL; ALPHA TOCOPHEROL; AMYLOID BETA PROTEIN; FATTY ACID; FREE RADICAL; MEMBRANE LIPID; SCAVENGER;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN SYNAPTOSOME; CONTROLLED STUDY; ELECTRON SPIN RESONANCE; GERBIL; LIPID BILAYER; LIPID COMPOSITION; LIPID PEROXIDATION; MALE; NEOCORTEX; NERVE CELL LESION; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SPIN LABELING; SYNAPTIC MEMBRANE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; CEREBRAL CORTEX; ELECTRON SPIN RESONANCE SPECTROSCOPY; FATTY ACIDS, NONESTERIFIED; GERBILLINAE; LIPID PEROXIDES; MALE; MEMBRANE LIPIDS; PEPTIDE FRAGMENTS; SPIN LABELS; STEARATES; SYNAPTOSOMES; VITAMIN E;

EID: 0032498829     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)01466-2     Document Type: Article

References (21)

1. [1] E.G. Bligh, W.J. Dyer, A rapid method of total lipid extraction and purification, Can. J. Biochem. Physiol. 37 (1959) 911-917.
2. [2] D.A. Butterfield, β-amyloid-associated free radical oxidative stress and neurotoxicity: implications for Alzheimer's disease, Chem. Res. Toxicol. 10 (1997) 518-526.
3. [3] D.A. Butterfield, K. Hensley, M. Harris, M.P. Mattson, J.M. Carney, β-Amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer's disease, Biochem. Biophys. Res. Commun. 200 (1994) 710-715.
4. [4] H.S. Dhillon, D. Donaldson, R.J. Dempsey, M.R. Prasad, Regional levels of free fatty acids and Evans Blue extravasation after experimental brain injury, J. Neurotrauma 11 (1994) 405-415.
5. [5] Y. Goodman, M.R. Steiner, S.M. Steiner, M.P. Mattson, Nordihydroguaiaretic acid protects hippocampal neurons against amyloid β-peptide toxicity, and attenuates free radical and calcium accumulation, Brain Res. 654 (1994) 171-176.
6. [6] M.E. Harris, K. Hensley, D.A. Butterfield, R.A. Leedle, J.M. Carney, Direct evidence of oxidative injury produced by the Alzheimer's amyloid beta protein (1-40) in cultured hippocampal neurons, Exp. Neurol. 132 (1995) 1-10.
7. [7] K. Hensley, J.M. Carney, M.P. Mattson, M. Aksenova, M. Harris, J.F. Wu, R.A. Floyd, D.A. Butterfield, A model for β-amyloid aggregation and neurotoxicity based on free radical generated by the peptide: relevance to Alzheimer's disease, Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 3270-3274.
8. [8] K. Hensley, N.C. Hall, W. Shaw, J.M. Carney, D.A. Butterfield, Electron paramagnetic resonance investigation of free radical induced alterations in neocortical synaptosomal membrane protein infrastructure, Free Radic. Biol. Med. 17 (1994) 321-331.
9. [9] R. Katzman, T. Saitoh, Advances in Alzheimer's disease, FASEB J. 4 (1991) 278-286.
10. [10] O.H. Lowry, N.J. Rosebrough, A.L. Farr, R.J. Randall, Protein measurement with the Folin phenol reagent, J. Biol. Chem. 193 (1951) 265-275.
11. 2+ homeostasis and cell death, J. Neurosci. 15 (1995) 6239-6249.
12. [12] R.J. Mark, M.A. Lovell, W.R. Markesbery, K. Uchida, M.P. Mattson, Evidence that 4-hydroxynonenal mediates disruption of ion homeostasis and neuronal death by amyloid-β peptide, J. Neurochem. 68 (1997) 255-264.
13. [13] R.P. Mason, J.D. Estermyer, J.F. Kelly, P.E. Mason, Alzheimer's disease amyloid β peptide 25-35 is localized in the membrane hydrocarbon core: X-ray diffraction analysis, Biochem. Biophys. Res. Commun. 222 (1996) 78-82.
14. +2 homeostasis Alzheimer's disease, Trends Neurosci. 16 (1993) 409-414.
15. [15] A.P. Pentland, A.R. Morrison, S.C. Jacobs, L.L. Hruza, J.S. Herbert, L. Packer, Tocopherol analogs suppress arachidonic acid metabolism via phospholipase inhibition, J. Biol. Chem. 267 (1992) 15578-15584.
16. 13C-NMR spectroscopy, Biochim. Biophys. Acta 819 (1985) 131-135.
17. [17] W. Pyror, N. Porter, Suggested mechanisms for the production of 4-hydroxy-2-nonenal from the autooxidation of polyunsaturated fatty acids, Free Radic. Biol. Med. 8 (1990) 541-543.
18. [18] M. Sano, C. Ernesto, R.G. Thomas, M.R. Klauber, K. Schafer, M. Grundman, P. Woodbury, J. Growdon, C.W. Cotman, E. Pfeiffer, L.S. Schneider, L.J. Thal, A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's disease cooperative study, New Engl. J. Med. 336 (17) (1997) 1216-1222.
19. [19] D.J. Selkoe, Amyloid β-protein and the genetics of Alzheimer's disease, J. Biol. Chem. 271 (1996) 18295-18298.
20. [20] R. Subramaniam, F. Roediger, B. Jordan, M.P. Mattson, J.N. Keller, G. Waeg, D.A. Butterfield, The lipid peroxidation product, 4-hydroxy-2-trans-nonenal, alters conformation of cortical synaptosomal membrane proteins, J. Neurochem. 69 (3) (1997) 1161-1169.
21. [21] R.P. White, Cerebrospinal fluid eicosanoids as an index of cerebrovascular status, Anal. N.Y. Acad. Sci. 570 (1989) 131-145.